Aura Biosciences, Inc. (AURA)
7.065
-0.02
(-0.35%)
USD |
NASDAQ |
Apr 16, 16:00
7.065
0.00 (0.00%)
After-Hours: 16:37
Aura Biosciences Cash from Investing (TTM) : 35.60M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Assertio Holdings, Inc. | -11.99M |
| Olema Pharmaceuticals, Inc. | -155.76M |
| Elicio Therapeutics, Inc. | -0.016M |
| ACADIA Pharmaceuticals, Inc. | -302.56M |
| Alnylam Pharmaceuticals, Inc. | 436.33M |